A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
For patients with relapsed and refractory aggressive non-Hodgkin's lymphoma
Non-Hodgkin's Lymphoma
DRUG: Filgrastim SD/01|DRUG: Paclitaxel|DRUG: Topotecan
For patients with relapsed and refractory aggressive non-Hodgkin's lymphoma